Trulieve Relief
I want to be sure everyone saw the good news on Trulieve ($TRLV) after the market closed Friday.
Trulieve was my Trade of the Week:
Trade of the Week: Buy TRLV ($8.05)
Trulieve’s (TRLV) shares have been under pressure because of the malaise in the cannabis space and the proposed sale of 2.5 million shares by the company’s founder, Kim Rivers.
As expressed in my cannabis update yesterday, I believe an extraordinary reward vs. risk exists today.
As to Trulieve, based on Rivers’ SEC reporting I believe she is close to completing her sales (which were previously planned for in a filing).
After she completes those sales I expect the company to implement their authorized company buyback.
I would further note that a large portion of the cannibas company’s operations are medical-use based, which has already been rescheduled.
Position: Long TRLV (S)
BY Doug Kass · Jun 24, 2026, 10:10 AM EDT
Positions: Long TRLV S




